Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.52 |
| ▸ | CA1 | P00915 | 13/20 | 0.52 |
| ▸ | CA12 | O43570 | 8/20 | 0.48 |
| ▸ | CA9 | Q16790 | 8/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19518816 | 0.85 | CA2 (0.53) | CA2CA1CA12CA9CA14 | |
| SCHEMBL21994276 | 0.82 | CA2 (0.50) | CA2CA1CA12CA9CA14 | |
| SCHEMBL29628688 | 0.81 | CA2 (0.57) | CA2CA1CA12CA9CA14 | |
| SCHEMBL6871649 | 0.81 | CA2 (0.57) | CA2CA1CA12CA9CA14 | |
| SCHEMBL12025007 | 0.80 | CA2 (0.61) | CA2CA1CA12CA9CA14 | |
| SCHEMBL12841398 | 0.79 | CA2 (0.59) | CA2CA1CA12CA9CA14 | |
| SCHEMBL12481467 | 0.79 | CA2 (0.52) | CA2CA1CA12CA9CA14 | |
| SCHEMBL15045357 | 0.78 | CNR1 (0.47) | — | |
| SCHEMBL17254234 | 0.75 | CA2 (0.50) | CA2CA1CA12CA9CA14 | |
| SCHEMBL17254862 | 0.75 | CA2 (0.50) | CA2CA1CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104540828-B | As the substituted pyrazoloquinazolone and pyrrolo- quinazolinone of the allosteric modulators of II group metabotropic glutamate receptors | 多曼治疗学公司 | 2017-06-13 | — | — | CN | disclosed |
| CN-104540828-A | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptors | DOMAIN THERAPEUTICS | 2015-04-22 | — | — | CN | disclosed |